Clinical significance of nontubeculous mycobacteria (NMT) idenified by HPLC in pulmonary specimens

M. Nowacka-Mazurek, R. Walkiewicz, R. Krenke, A. Safianowska, A. Fangrat, H. Grubek-Jaworska, R. Chazan (Warsaw, Poland)

Source: Annual Congress 2003 - Diagnosis of tuberculosis
Session: Diagnosis of tuberculosis
Session type: Oral Presentation
Number: 1095
Disease area: Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Nowacka-Mazurek, R. Walkiewicz, R. Krenke, A. Safianowska, A. Fangrat, H. Grubek-Jaworska, R. Chazan (Warsaw, Poland). Clinical significance of nontubeculous mycobacteria (NMT) idenified by HPLC in pulmonary specimens. Eur Respir J 2003; 22: Suppl. 45, 1095

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
From detection of nontuberculous mycobacteria (NTM) in pulmonary specimens to pulmonary infections
Source: Eur Respir J 2004; 24: Suppl. 48, 420s
Year: 2004

Novel sequence-based assay for detection of pyrazinamide-resistant mycobacterium tuberculosis in clinical specimens from patients with pulmonary tuberculosis in Russia
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011


Diagnostic value of PCR-RT for the detection of DNA Mycobacterium tuberculosis complex (MBT) in blood from patient with pulmonary tuberculosis (PT)
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009

Highly specific differentiation of mycobacterium avium subspec. paratuberculosis (MAP) in comparison to other mycobacteria using GC IMS-spectral analysis from headspace
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015


Significance of Mycobacterium Avium Complex (MAC) isolation in bronchoscopic samples
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018




Semiquantitation of tuberculosis bacilli (MTB) and nontuberculous mycobacteria (NTM) in sputum by a new nucleic acid amplification test (NAAT)
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018


Detection of non-tuberculosis mycobacteria (NTM) in bronchoscopy specimens using molecular techniques
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Clinical and bacteriological features of empyema (E.) of extrapulmonary causes (EPC>)
Source: Eur Respir J 2004; 24: Suppl. 48, 52s
Year: 2004

Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012


Primary resistance (PR) of mycobacterium tuberculosis (MBT) to antimicrobial drugs (AMBD) in patients (P) with destructive pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 655s
Year: 2004

Isolation and identification of non-tuberculous mycobacteria (NTM)
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009


Comparison of DNA strip assay and high performance liquid chromatography (HPLC) analysis of mycolic acids for identification of mycobacterial isolates to the species level
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Frequency of mycobacteriosis among the patients with positive cultures of nontuberculous mycobacteria (NTM) – 5 year study
Source: Eur Respir J 2004; 24: Suppl. 48, 190s
Year: 2004

Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006

Clinical significance of Mycobacterium tuberculosis (MBT) DNA detection in bronchoalveolar lavage and bronchial biopsy in HIV-infected patients
Source: Eur Respir J 2005; 26: Suppl. 49, 690s
Year: 2005

Mycobacterium tuberculosis DNA detection in urine samples from pulmonary tuberculosis patients
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease
Source: Eur Respir J, 55 (1) 1901300; 10.1183/13993003.01300-2019
Year: 2020



Serological test and chest computed tomography findings in patients with Mycobacterium avium complex lung disease
Source: Eur Respir J 2007; 29: 1217-1223
Year: 2007



Nucleic acid amplification tests (naat): diagnostic value for pulmonary tuberculosis
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009